BUY Cipla Ltd. — Axis Securities
byAxis SecuritiesHorizon: NA (inferred 1 year)24 Jul 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
7 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·28 Sept · 4w ago
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·23 Oct · 2d ago
Cipla Disappointed By Maharashtra FDA Action, Says Pune Warehouse Complies With Protocols
NewsNdtv-Profit·2 Oct · 3w ago
Maharashtra FDA Cancels Cipla Pune Warehouse Drug Licences Over Violations
NewsNdtv-Profit·2 Oct · 3w ago
3 other SEBI-registered advisors have active long-term SELL calls on this stock
Advisor consensus · same horizon·24 Jul · 3mo ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Cipla
- BUY — Ashish Bahety, Profitmart Securities29 Sept 2026 · Same day · target ₹1,420 · Expired
- BUY — Ashish Bahety, Profitmart Securities29 Sept 2026 · Same day · target ₹1,430 · Expired
- BUY — Rajesh Palviya, Axis Securities29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY — Arun Kumar Mantri28 Sept 2026 · ~1 year · target ₹1,900 · Active
- BUY — Arun Kumar Mantri25 Sept 2026 · Same day · target ₹1,428 · SL hit
More from Axis Securities
- BUY Eternal22 Oct 2026 · ~1 year · target ₹390 · Active
- BUY CREDITACCESS GRAMEEN22 Oct 2026 · ~1 year · target ₹1,405 · Active
- BUY CCL Products (India)19 Oct 2026 · ~1 year · target ₹1,255 · Active
- BUY Federal Bank19 Oct 2026 · ~1 year · target ₹405 · Active
- BUY LTM19 Oct 2026 · ~1 year · target ₹4,960 · Active

